Genetic variability in the cholecystokinin A receptor affects lipid profile and glucose tolerance in patients with polycystic ovary syndrome
Introduction Cholecystokinin (CCK) is involved in several metabolic pathways, and CCK agonists are considered as a potential novel treatment option in populations with increased metabolic risk, including polycystic ovary syndrome (PCOS). As genetic variability of cholecystokinin A and B receptor gen...
Saved in:
Main Authors: | Eva Drnovsek, Mojca Jensterle, Katja Goričar, Sara Redenšek, Andrej Janež, Irina Milisav, Vita Dolžan |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2022-06-01
|
Series: | Archives of Medical Science |
Subjects: | |
Online Access: | https://www.archivesofmedicalscience.com/Genetic-variability-in-the-cholecystokinin-A-receptor-affects-lipid-profile-and-glucose,150867,0,2.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
by: Barbara Šenk, et al.
Published: (2018-01-01) -
The association between melatonin hormone and reproductive hormones in polycystic ovary syndrome: A case–control study
by: Ban Jabir Edan, et al.
Published: (2024-01-01) -
Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01) -
Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01) -
Quality of Life in The Community of Women with Polycystic Ovary Syndrome (PCOS): A Phenomenology Study
by: Neina Qonita Istiqomah, et al.
Published: (2023-12-01)